Concepedia

Antonio Palumbo

AP

3

Publications

120

Citations

3

H-Index

2014

Active since

Affiliations

National and Kapodistrian University of Athens(Current)

Instituto de Investigación Biomédica de Salamanca

Heidelberg University

Erasmus MC Cancer Institute

Azienda Ospedaliera Citta' della Salute e della Scienza di Torino

Antonio Palumbo is an author at National and Kapodistrian University of Athens specializing in oncology, cell transplantation, and medicine.

Top concepts

Publications per year

2014–2022

3

Publications

3

Upfront autologous stem cell transplantation (ASCT) versus novel agent-based therapy for multiple myeloma (MM): A randomized phase 3 study of the European Myeloma Network (EMN02/HO95 MM trial).

Michèle Cavo, Antonio Palumbo, Sonja Zweegman et al. · Journal of Clinical Oncology · 2016 · 65 citations

, , +22

Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial

Meletios Α. Dimopoulos, Paul G. Richardson, Nizar J. Bahlis et al. · The Lancet Haematology · 2022 · 44 citations

, , +8

A Randomized Phase III Trial of Melphalan and Dexamethasone (MDex) Versus Bortezomib, Melphalan and Dexamethasone (BMDex) for Untreated Patients with AL Amyloidosis

Efstathios Kastritis, Xavier Leleu, Bertrand Arnulf et al. · Blood · 2014 · 11 citations

Rows per page

1–3 of 3